U-Neuron Biomedical Inc (TPEX:6973)
48.00
-5.70 (-10.61%)
Nov 20, 2026, 1:58 PM CST
U-Neuron Biomedical Market Cap
U-Neuron Biomedical has a market cap or net worth of 1.42 billion as of November 20, 2026. It is the 30,551st most valuable company in the world and the 1,754th biggest in Taiwan. Its market cap has increased by 11.63% in one year.
Market Cap
1.42B
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#1,754 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since July 20, 2023, U-Neuron Biomedical's market cap has increased from 1.36B to 1.42B, an increase of 4.35%. That is a compound annual growth rate of 1.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 1.48B | 32.45% |
| Dec 31, 2025 | 1.12B | -9.44% |
| Dec 31, 2024 | 1.24B | -30.25% |
| Dec 29, 2023 | 1.77B | 30.43% |
| Jul 20, 2023 | 1.36B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 3D Global Biotech | 1.76B |
| Gwo Xi Stem Cell Applied Technology Co. , | 1.66B |
| G&E Herbal Biotechnology | 1.55B |
| Anti-Microbial Savior BioteQ | 1.35B |
| GenMont Biotech Incorporation | 1.33B |
| Synbio Tech | 1.32B |
| Greenyn Biotechnology | 1.21B |
| NeoCore Technology | 1.20B |